Explore the full directors' dealings record of 펨토바이오메드, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 펨토바이오메드 has recorded 27 insider filings. The latest transaction was disclosed on 6 November 2025 (Other). Among the most active insiders: 이상현. The full history is free.
27
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
14 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.